A phase 1 study adding pitavastatin to venetoclax therapy in AML and CLL/SLL: a mechanism-based drug repurposing strategy.
作者信息
Brem Elizabeth A, Shieh Kevin, Juarez Dennis, Buono Roberta, Jeyakumar Deepa, O'Brien Susan, Taylor Thomas H, Fruman David A
机构信息
Division of Hematology/Oncology, Department of Medicine, University of California, Irvine, Orange, CA.
Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange, CA.
出版信息
Blood Neoplasia. 2024 Aug 28;1(4):100036. doi: 10.1016/j.bneo.2024.100036. eCollection 2024 Dec.
Abstract
摘要
Zotero 插件